These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 27977808)
1. Activated p53 with Histone Deacetylase Inhibitor Enhances L-Fucose-Mediated Drug Delivery through Induction of Fucosyltransferase 8 Expression in Hepatocellular Carcinoma Cells. Okagawa Y; Takada K; Arihara Y; Kikuchi S; Osuga T; Nakamura H; Kamihara Y; Hayasaka N; Usami M; Murase K; Miyanishi K; Kobune M; Kato J PLoS One; 2016; 11(12):e0168355. PubMed ID: 27977808 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of autophagy significantly enhances combination therapy with sorafenib and HDAC inhibitors for human hepatoma cells. Yuan H; Li AJ; Ma SL; Cui LJ; Wu B; Yin L; Wu MC World J Gastroenterol; 2014 May; 20(17):4953-62. PubMed ID: 24833845 [TBL] [Abstract][Full Text] [Related]
3. Sorafenib increases efficacy of vorinostat against human hepatocellular carcinoma through transduction inhibition of vorinostat-induced ERK/NF-κB signaling. Hsu FT; Liu YC; Chiang IT; Liu RS; Wang HE; Lin WJ; Hwang JJ Int J Oncol; 2014 Jul; 45(1):177-88. PubMed ID: 24807012 [TBL] [Abstract][Full Text] [Related]
4. α-Fetoprotein promoter-driven Cre/LoxP-switched RNA interference for hepatocellular carcinoma tissue-specific target therapy. Peng YF; Shi YH; Ding ZB; Zhou J; Qiu SJ; Hui B; Gu CY; Yang H; Liu WR; Fan J PLoS One; 2013; 8(2):e53072. PubMed ID: 23468839 [TBL] [Abstract][Full Text] [Related]
5. Aspirin minimized the pro-metastasis effect of sorafenib and improved survival by up-regulating HTATIP2 in hepatocellular carcinoma. Lu L; Sun HC; Zhang W; Chai ZT; Zhu XD; Kong LQ; Wang WQ; Zhang KZ; Zhang YY; Zhang QB; Ao JY; Li JQ; Wang L; Wu WZ; Tang ZY PLoS One; 2013; 8(5):e65023. PubMed ID: 23741443 [TBL] [Abstract][Full Text] [Related]
6. Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation. Zhai B; Jiang X; He C; Zhao D; Ma L; Xu L; Jiang H; Sun X Tumour Biol; 2015 Apr; 36(4):2323-34. PubMed ID: 25416439 [TBL] [Abstract][Full Text] [Related]
7. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1. Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114 [TBL] [Abstract][Full Text] [Related]
8. In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance through Inhibition of Caspase-3-Mediated Apoptosis. Fornari F; Pollutri D; Patrizi C; La Bella T; Marinelli S; Casadei Gardini A; Marisi G; Baron Toaldo M; Baglioni M; Salvatore V; Callegari E; Baldassarre M; Galassi M; Giovannini C; Cescon M; Ravaioli M; Negrini M; Bolondi L; Gramantieri L Clin Cancer Res; 2017 Jul; 23(14):3953-3965. PubMed ID: 28096271 [No Abstract] [Full Text] [Related]
9. Pregnane X receptor mediates sorafenib resistance in advanced hepatocellular carcinoma. Feng F; Jiang Q; Cao S; Cao Y; Li R; Shen L; Zhu H; Wang T; Sun L; Liang E; Sun H; Chai Y; Li X; Liu G; Yang R; Yang Z; Yang Y; Xin S; Li BA Biochim Biophys Acta Gen Subj; 2018 Apr; 1862(4):1017-1030. PubMed ID: 29369785 [TBL] [Abstract][Full Text] [Related]
10. Notch3 inhibition enhances sorafenib cytotoxic efficacy by promoting GSK3b phosphorylation and p21 down-regulation in hepatocellular carcinoma. Giovannini C; Baglioni M; Baron Toaldo M; Ventrucci C; D'Adamo S; Cipone M; Chieco P; Gramantieri L; Bolondi L Oncotarget; 2013 Oct; 4(10):1618-31. PubMed ID: 24113128 [TBL] [Abstract][Full Text] [Related]
11. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2. Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350 [TBL] [Abstract][Full Text] [Related]
12. Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1. Zhai JM; Yin XY; Lai YR; Hou X; Cai JP; Hao XY; Liang LJ; Zhang LJ Cancer Chemother Pharmacol; 2013 May; 71(5):1255-64. PubMed ID: 23435877 [TBL] [Abstract][Full Text] [Related]
13. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma. Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973 [TBL] [Abstract][Full Text] [Related]
14. Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo. Chen CH; Chen MC; Wang JC; Tsai AC; Chen CS; Liou JP; Pan SL; Teng CM Clin Cancer Res; 2014 Mar; 20(5):1274-1287. PubMed ID: 24520095 [TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 upregulates Fut8 expression by activating the Wnt/β-catenin pathway to enhance HCC cell proliferative and invasive ability. Zhang C; Wu Q; Huang H; Chen X; Huang T; Li W; Zhang J; Liu Y Cell Biol Int; 2020 Nov; 44(11):2202-2212. PubMed ID: 32710651 [TBL] [Abstract][Full Text] [Related]
16. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway. He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma. Zheng M; Xu H; Liao XH; Chen CP; Zhang AL; Lu W; Wang L; Yang D; Wang J; Liu H; Zhou XZ; Lu KP Oncotarget; 2017 May; 8(18):29771-29784. PubMed ID: 28404959 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of the Wnt/β-catenin signaling pathway improves the anti-tumor effects of sorafenib against hepatocellular carcinoma. Lin HH; Feng WC; Lu LC; Shao YY; Hsu CH; Cheng AL Cancer Lett; 2016 Oct; 381(1):58-66. PubMed ID: 27431312 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs. Cheng L; Gao S; Song X; Dong W; Zhou H; Zhao L; Jia L Oncotarget; 2016 Sep; 7(38):61199-61214. PubMed ID: 27533464 [TBL] [Abstract][Full Text] [Related]
20. Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivo. Shao H; Gao C; Tang H; Zhang H; Roberts LR; Hylander BL; Repasky EA; Ma WW; Qiu J; Adjei AA; Dy GK; Yu C J Hepatol; 2012 Jan; 56(1):176-83. PubMed ID: 21835141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]